Hospira Water 30ml | Bacteriostatic Water

Bacteriostatic Water for Injection, USP, manufactured by Hospira, is a sterile, nonpyrogenic aqueous solution containing 0.9% (9 mg/mL) benzyl alcohol. This preparation is supplied in 30 mL multiple-dose vials, packaged in a 25-count unit. The inclusion of benzyl alcohol serves as a bacteriostatic preservative, inhibiting microbial growth following the initial puncture of the vial septum and subsequent withdrawal of contents.

The primary clinical indication for Bacteriostatic Water for Injection is its use as a diluent for parenteral drug products that necessitate reconstitution or dilution prior to administration. It is specifically indicated for use with compatible injectable medications intended for intravenous, intramuscular, or subcutaneous routes, as directed by the instructions for the specific drug product. It is crucial to note that this product is not intended for direct therapeutic injection. Its function is solely as a sterile diluent to facilitate the preparation of other injectable medications.

Key specifications include:

• Product Name:Bacteriostatic Water for Injection, USP

• Active Preservative: Benzyl Alcohol (0.9% w/v)

• Volume per Vial: 30 mL

• Packaging Configuration:25 vials per carton

• Sterility Assurance:Manufactured under aseptic conditions to meet USP standards for sterility and nonpyrogenicity.

• Administration Guidance:Must be used with aseptic technique to maintain sterility during admixture and withdrawal. For use as a diluent only.

• Regulatory Classification:Prescription required (Rx).

• Storage Conditions:Maintain at controlled room temperature, adhering to manufacturer-specified parameters.

The use of Bacteriostatic Water for Injection is contra-indicated in neonates and infants due to the potential toxicity associated with benzyl alcohol in this patient population. Healthcare professionals must adhere strictly to aseptic techniques to prevent microbial contamination of the solution and the admixture preparation. Compatibility with specific drug formulations should be confirmed prior to use.